Virus-related matters will dominate the actions of senior living owners and operators for the time being, industry leaders told McKnight’s Senior Living.
Many are viewing the vaccine as a gift of sorts, a solution to end the months of extra safety precautions and social isolation that everyone has endured. But if you have staff members or residents who remain leery, your fellow operators have some suggestions to alleviate their concerns.
As 2020 was ending, President Trump signed a $900 billion COVID-19 relief bill that adds $3 billion to the Provider Relief Fund. That aid can’t come fast enough for assisted living providers, according to a recent survey.
The federal public health emergency declared due to COVID-19, which is set to expire Jan. 23, should be extended until five criteria are met, American Health Care Association / National Center for Assisted Living President and Chief Executive Officer Mark Parkinson said in a Dec. 28 letter to Health and Human Services Secretary Alex M. Azar.
Wednesday is the deadline for nominations for the McKnight’s Women of Distinction awards. This year’s program includes an additional awards category, Veteran VIPs.
In one of two cases with assisted living connections, President Donald Trump has commuted the sentence of Philip Esformes, the former assisted living and skilled nursing facility owner who was sentenced to 20 years in prison for his role in a case that the federal government valued at $1 billion and described as “the largest healthcare fraud scheme charged by the U.S. Justice Department.”
A $900 billion COVID-19 relief bill is on its way to the president’s desk after being passed by both houses of Congress by late Monday. Trade associations representing senior living operators, however, say they are disappointed in its provisions.
The $1.4 trillion appropriations omnibus spending bill advanced by congressional leaders on Monday includes an increase of more than $300 million in funding for dementia research at the National Institutes of Health for fiscal year 2021. With this increase, annual funding for NIH research into Alzheimer’s disease and other dementias would top $3.1 billion.
A year ago, nobody in the U.S. senior living industry would have predicted that a pandemic would upend everyone’s personal and professional lives in 2020. But COVID-19 undoubtedly was the story of the year, permeating almost all other news in some way from March onward. But other big stories drew attention as well.